Skip to main content
. 2020 Nov 18;1(11):100254. doi: 10.1016/j.xcrp.2020.100254

Figure 4.

Figure 4

Dox@MIL-101(Cr) and Dox@UiO-66 Are Therapeutically Efficacious and Have Different Dox Delivery Profiles

(A–C) RTCA of 3 cancer cell lines treated with empty MIL-101(Cr), Dox@MIL-101(Cr), and free Dox. The cancer cell lines were allowed to grow for 24 h after the initial cell seeding at time point 0. Treatment administration took place at 24 h. The data are presented as means ± SDs (n = 6).

(D–F) RTCA of 3 cancer cell lines treated with empty UiO-66, Dox@UiO-66, and free Dox. The cancer cell lines were allowed to grow for 24 h after the initial cell seeding at time point 0. Treatment administration took place at 24 h. The data are presented as means ± SDs (n = 6).